Pharmacogenomics Unknown Status Phase 4 Trials for Chlormadinone acetate (DB15903)

Also known as: Pharmacogenomic / Pharmacogenomics (qualifier value) / Pharmacogenomic specialist (occupation)

IndicationStatusPhase
DBCOND0047497 (Pharmacogenomics)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01123538Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile